Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Enochian Biosciences Inc (NQ: ENOB ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Aug 4, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Enochian Biosciences Inc < Previous 1 2 3 Next > BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) Releases CEO Shareholder Message January 16, 2024 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) CEO Featured Guest in Recent Proactive Interview November 22, 2023 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) CEO Participating in Webinar Focused on Future Health Tech October 20, 2023 Via Investor Brand Network BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) CEO Releases Shareholder Letter Regarding Agreement to Combine with Leading AI Company October 02, 2023 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) Enters Definitive Agreement to Combine with Leading AI Tech GEDi Cube September 29, 2023 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) Congratulates GEDiCube on New Joint Effort Clinical Trials August 30, 2023 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Eyes Clear Path to IND Submission for Innovative Cancer Platform August 23, 2023 Via Investor Brand Network Exposures Product Safety BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) CEO Discusses Substantial Scientific, Product Development Advances in Letter to Shareholders August 18, 2023 Via Investor Brand Network Exposures Product Safety BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Announces Presentation of ‘Impressive’ Results from Proof-of-Concept Studies August 17, 2023 Via Investor Brand Network BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Eyes Bright Future in Advancing Potentially Curative Therapies August 16, 2023 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Committed to Rapid Advancement of Its Proprietary Oncology Platform August 15, 2023 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Renovaro BioSciences (NASDAQ: RENB), GEDi Cube Announce LOI to Merge, Focus on Fight Against Cancer August 09, 2023 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB), GEDi Cube Announce LOI to Merge, Focus on Fight Against Cancer August 09, 2023 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence Enochian BioSciences Inc. Announces Adjournment of 2023 Annual Stockholder Meeting June 23, 2023 From Enochian BioSciences, Inc. Via GlobeNewswire Enochian BioSciences Announces that its Cancer Platform Remains on Track for Trials in Humans Following FDA Review June 08, 2023 From Enochian BioSciences, Inc. Via GlobeNewswire Enochian BioSciences’ CEO Letter to Shareholders April 03, 2023 Turning the Page; A Promising Future From Enochian BioSciences, Inc. Via GlobeNewswire Enochian BioSciences Announces a Scientific Presentation of Proof-of-Concept Studies for a Potential Therapy for Cancers with a Poor Life Expectancy by a Leading Researcher March 29, 2023 From Enochian BioSciences, Inc. Via GlobeNewswire Enochian BioSciences Achieves Full Compliance with NASDAQ Filing Requirements March 13, 2023 From Enochian BioSciences, Inc. Via GlobeNewswire Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended December 31, 2022 February 23, 2023 From Enochian BioSciences, Inc. Via GlobeNewswire Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended September 30, 2022 November 30, 2022 From Enochian BioSciences, Inc. Via GlobeNewswire NASDAQ:ENOB Long-Term Investor Notice: Investigation over Potential Wrongdoing at Enochian Biosciences, Inc. November 09, 2022 San Diego, CA -- (SBWIRE) -- 11/09/2022 -- Certain directors of Enochian Biosciences, Inc. are under investigation over possible breaches of fiduciary duties. Via SBWire Enochian BioSciences Forges Ahead With Focused Approach, Promising Future October 24, 2022 From Enochian BioSciences, Inc. Via GlobeNewswire Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Annual Report on Form 10-K October 21, 2022 From Enochian BioSciences, Inc. Via GlobeNewswire Enochian BioSciences Awarded U.S. Patent For Its Promising Oncology Platform October 17, 2022 Initial, Pre-Clinical Animal Study Results Show Potential To Effectively Treat Pancreatic Cancer From Enochian BioSciences, Inc. Via GlobeNewswire ENOCHIAN DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Enochian Biosciences, Inc. and Encourages Investors to Contact the Firm September 24, 2022 From Bragar Eagel & Squire, P.C. Via Business Wire The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Enochian Biosciences, Inc. (ENOB) September 23, 2022 From The Law Offices of Frank R. Cruz Via Business Wire ENOB FINAL DEADLINE MONDAY: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Enochian BioSciences, Inc. Investors to Secure Counsel Before Important September 26 Deadline in Securities Class Action - ENOB September 21, 2022 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal ENOB FINAL DEADLINE NOTICE: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Enochian BioSciences, Inc. Investors to Secure Counsel Before Important September 26 Deadline in Securities Class Action - ENOB September 15, 2022 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Enochian BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ENOB September 11, 2022 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Enochian BioSciences, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ENOB September 05, 2022 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
